Clinical trials
Observational Ventricular Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2011 | 3 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 7 |
| Unknown status | 7 |
| Terminated | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 2 |
| Berlin Heart GmbH | 2 |
| Eko Devices, Inc. | 2 |
| University Hospital, Strasbourg, France | 2 |
| Zoll Medical Corporation | 2 |
| Assiut University | 1 |
| Barts & The London NHS Trust | 1 |
| Berlin Heart, Inc | 1 |
| Chinese PLA General Hospital | 1 |
| Corrado Tomasi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ventricular Dysfunction | 34 |
| Heart Failure | 17 |
| Cardiovascular Diseases | 7 |
| Tachycardia, Ventricular | 6 |
| Cardiomyopathies | 5 |
| Heart Diseases | 5 |
| Ventricular Dysfunction, Left | 5 |
| Ventricular Fibrillation | 5 |
| Arrhythmias, Cardiac | 4 |
| Bradycardia | 3 |
Trials
Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.